SORBISTERIT

This brand name is authorized in Estonia, Lithuania, Netherlands, South Africa, Spain.

Active ingredients

The drug SORBISTERIT contains one active pharmaceutical ingredient (API):

1
UNII 199995D30M - CALCIUM PHENOLSULFONATE
 
Read more about Polystyrene sulfonate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
V03AE01 Polystyrene sulfonate V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
Discover more medicines within V03AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1271775, 1501928, 1683693
ES Centro de información online de medicamentos de la AEMPS 69234
LT Valstybinė vaistų kontrolės tarnyba 1004943, 1057159, 1077079, 1081255, 1084661
NL Z-Index G-Standaard 13485512
NL Z-Index G-Standaard, PRK 130664
ZA Health Products Regulatory Authority 43/18.3/0701

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈